Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tracery Ophthalmics has developed a clinical-stage functional ophthalmic imaging and AI analytics platform that provides clearer visualization and novel phenotypes of dry age-related macular degeneration versus standard fundus autofluorescence, and is being evaluated prospectively for use in AMD diagnosis, staging, and precision clinical trial enrollment[1][3][7][8].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tracery Ophthalmics.